Xontogeny

Deep experience to guide your innovation

Xontogeny’s team has experience across scientific diligence, drug and medical technology development and operations from preclinical stages through commercialization. Through the efforts of the team, Xontogeny supports and stays connected with its entrepreneurs and larger community of collaborators by providing strategic and investment leadership to create successful outcomes across its portfolio of companies.

Team

Chris Garabedian

Chris Garabedian

Chairman & CEO
Fred Callori

Fred Callori

SVP, Corporate Development
Ben Askew

Ben Askew, Ph.D.

Partner, Research & Development
Katherine Ruf

Katherine Ruf

VP, Legal
Gianna Hoffman Luca

Gianna Hoffman-Luca, Ph.D.

Principal
Takeru Furuya

Takeru Furuya, Ph.D.

Senior Associate
Wendy Cort

Wendy Cort

Director, Administration
Heather Petty

Heather Petty

Associate Director, Program Development
Thien Nguyen

Thien Nguyen, Ph.D.

Associate
Jayanth Batchu

Jayanth Batchu

Entrepreneur in Residence
Brad Murray

Brad Murray

Advisor
Shobha Parthasarathi

Shobha Parthasarathi, Ph.D.

Advisor
Holly Purcell

Holly Purcell

Advisor
Melissa Rewlinowski

Melissa Rewolinski Ph.D.

R&D Advisor
Ann Taylor

Ann Taylor, M.D.

R&D Advisor

Board

Chris Garabedian

Chris Garabedian founded Xontogeny in June of 2016 to support multiple promising technologies from early development through clinical proof of concept.

Joe Edelman

Joe Edelman founded the hedge fund Perceptive Advisors, LLC in 1999, to further the progress of promising companies within the life sciences industry.

Adam Stone

Adam Stone joined Perceptive Advisors, a hedge fund focused on supporting the progress of the life sciences industry, in 2006.